Insulin receptor (IR) and insulin-like growth factor-1 (IGF-1R) are both critical in the progression of cancer, particularly in tumorigenesis and the development of cancer drug resistance due to cross-talk between IGF-1R and IR signaling pathways [21,22,23,24]. Here, INSR is linked to cancer.